Apyx Medical Corporation APYX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.88M | 12.49M | 19.16M | 12.88M | 11.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.88M | 12.49M | 19.16M | 12.88M | 11.37M |
| Cost of Revenue | 5.01M | 4.57M | 7.17M | 4.58M | 4.29M |
| Gross Profit | 8.87M | 7.93M | 12.00M | 8.30M | 7.08M |
| SG&A Expenses | 9.88M | 8.07M | 11.04M | 8.33M | 8.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.69M | 13.40M | 19.15M | 13.71M | 13.95M |
| Operating Income | -1.81M | -911.00K | 11.00K | -832.00K | -2.57M |
| Income Before Tax | -2.95M | -2.00M | -1.15M | -1.88M | -3.69M |
| Income Tax Expenses | 124.00K | 143.00K | 94.00K | 78.00K | 49.00K |
| Earnings from Continuing Operations | -3.07M | -2.14M | -1.24M | -1.96M | -3.74M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -171.00K | 35.00K | -59.00K | -29.00K | -40.00K |
| Net Income | -3.24M | -2.11M | -1.30M | -1.98M | -3.78M |
| EBIT | -1.81M | -911.00K | 11.00K | -832.00K | -2.57M |
| EBITDA | -1.61M | -709.00K | 232.00K | -668.00K | -2.44M |
| EPS Basic | -0.07 | -0.05 | -0.03 | -0.05 | -0.09 |
| Normalized Basic EPS | -0.05 | -0.03 | -0.02 | -0.03 | -0.06 |
| EPS Diluted | -0.07 | -0.05 | -0.03 | -0.05 | -0.09 |
| Normalized Diluted EPS | -0.05 | -0.03 | -0.02 | -0.03 | -0.06 |
| Average Basic Shares Outstanding | 43.85M | 43.74M | 42.16M | 40.75M | 40.73M |
| Average Diluted Shares Outstanding | 43.85M | 43.74M | 42.16M | 40.75M | 40.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |